Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders.
Omeros stock last closed at $11.95, up 1.19% from the previous day, and has increased 37.83% in one year. It has overperformed other stocks in the Biotechnology industry by 0.71 percentage points. Omeros stock is currently +305.08% from its 52-week low of $2.95, and -32.29% from its 52-week high of $17.65.
There are currently 70.9M OMER shares outstanding. The market cap of OMER is $847.26M. In the past 24 hours, 838,000 OMER shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy OMER stock.
Based on our research, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, you'll need to fill out some personal details so you can invest in OMER stock today.
Now that you've finished signing up on a investment app, you can securely and quickly fund your account:
Watch the tutorial below for more details depositing funds into your brokerage account.
After you have chosen the best place to buy Omeros stock, it's absolutely critical to analyze their stock prior to buying, so you can wrap your head around the risk as well as the upside.
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on OMER's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge OMER's fair value.
You can access additional valuation analysis on OMER's stock here.
Out of 3 Equities analysts who research OMER, the consensus analyst rating on Omeros is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Omeros stock forecast page.
In the past year, insiders at OMER have sold more shares than they have bought.
David J. Borges, VP Finance CAO of OMER, was the latest OMER insider to buy. They bought $91,800.00 worth of OMER shares on Jan 13, 2026.
Learn more about who owns OMER stock here.
No, Omeros doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary order types:
Hit the Open button and your broker will execute your order.
If you need additional help investing in stocks on eToro, watch the how to video below:
Now that you own some shares in OMER, you'll want to keep up with your new investment.
Create a watchlist to get notified of important updates regarding your OMER stock.
To summarize, here are the 6 steps to buy stock in Omeros:
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Omeros, add OMER to your watchlist by clicking the button below.